US researchers are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Low doses of a compound that interferes with retinoic acid receptors (RARs) stopped sperm production in male mice with no apparent side effects. And crucial for a contraceptive, normal fertility was restored soon after drug administration was terminated.
Read more at Columbia University Medical Center
Academic rigor, journalistic flair
Want to write?
Write an article and join a growing community of more than 182,400 academics and researchers from 4,942 institutions.